CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 111,203 shares at an average $1.28 ($142,512)
- 4 Open-market buy Director bought 88,797 shares at an average $1.24 ($110,500)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Other acquisition Director acquired 27,982,529 shares (other)
- 4 Open-market buy Chief Operating Officer bought 10,000 shares at $1.05 ($10,500)
- 4 Open-market buy CEO and President bought 19,925 shares at $1.06 ($21,121)
- 4 Other acquisition Director acquired 27,982,529 shares (other)
- 4 Other disposition 10% owner disposed of 27,982,529 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 16 · 305 filings